Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma
- 1 May 2016
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (10) , 2475-2480
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Emerging Trabecular Outflow DrugsJournal of Ocular Pharmacology and Therapeutics, 2013
- Analysis of α2-adrenergic Receptors and Effect of Brimonidine on Matrix Metalloproteinases and Their Inhibitors in Human Ciliary BodyInvestigative Ophthalmology & Visual Science, 2009
- Rho GTPase/Rho Kinase Inhibition as a Novel Target for the Treatment of GlaucomaBioDrugs, 2007
- The Structure of Dimeric ROCK I Reveals the Mechanism for Ligand SelectivityJournal of Biological Chemistry, 2006
- Glaucoma and its treatment: A reviewAmerican Journal of Health-System Pharmacy, 2005
- Contribution of ROCK in Contraction of Trabecular Meshwork: Proposed Mechanism for Regulating Aqueous Outflow in Monkey and Human EyesJournal of Pharmaceutical Sciences, 2005
- Effects of topical application of a 2% solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogsAmerican Journal of Veterinary Research, 2001
- Aqueous Humor Flow in Normal Human Eyes Treated With Brimonidine and Timolol, Alone and in CombinationArchives of Ophthalmology (1950), 2001
- Effects on Intraocular Pressure and Side Effects of 0.005% Latanoprost Applied Once Daily, Evening or MorningOphthalmology, 1995
- The Mechanism of Timolol in Lowering Intraocular PressureArchives of Ophthalmology (1950), 1978